Japan Single Molecule, Real-Time (Smrt) Sequencing Market Size & Outlook
- Biotechnology
- Sequencing technology
- Single Molecule, Real-Time (SMRT) Sequencing Market Outlook
- Sequencing technology
Japan Single Molecule, Real-Time (Smrt) Sequencing Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask Prism AI about the single molecule, real-time (smrt) sequencing market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Japan single molecule, real-time (smrt) sequencing market highlights
- The Japan single molecule, real-time (smrt) sequencing market generated a revenue of USD 2,894.3 million in 2020 and is expected to reach USD 16,829.9 million by 2030.
- The Japan market is expected to grow at a CAGR of 19.2% from 2021 to 2030.
- In terms of segment, sequencing was the largest revenue generating workflow in 2020.
- Sequencing is the most lucrative workflow segment registering the fastest growth during the forecast period.
Single molecule, real-time (smrt) sequencing market data book summary
| Market revenue in 2020 | USD 2,894.3 million |
| Market revenue in 2030 | USD 16,829.9 million |
| Growth rate | 19.2% (CAGR from 2020 to 2030) |
| Largest segment | Sequencing |
| Fastest growing segment | Sequencing |
| Historical data | 2018 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pre-Sequencing, Sequencing, Data Analysis |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Pacific Biosciences of California Inc, Roche Holding AG, Oxford Nanopore Technologies PLC, Agilent Technologies, Fluidigm Corporation, Takara Bio Inc, BioLine Rx Ltd ADR, ArcherDX |
Other key industry trends
- In terms of revenue, Japan accounted for 2.5% of the global single molecule, real-time (smrt) sequencing market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China single molecule, real-time (smrt) sequencing market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 12,706.0 million by 2030.
The increasing number of rare genetic diseases, moving the attention of Japanese scientists towards rare disease research and the rise in adoption of SMRT sequencing technology more rapidly.
According to surveys conducted by the Japan Agency for Medical Research and Development (AMED) have represented that there are over 37,000 undiagnosed diseases cases, demonstrating that diagnosing patients with such rare and undiagnosed disorders are a major concern for the country.
However, researchers at Yokohama city university and other institutes in Japan established SMRT sequencing to research the genetic mechanism causes for progressive myoclonic epilepsy.
Key Regions:U.S., UK, Japan, Brazil, Saudi Arabia
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Single Molecule, Real-Time (SMRT) Sequencing Market Scope
Single Molecule, Real-Time (SMRT) Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| Fluidigm Corporation | View profile | 501-1000 | South San Francisco, California, United States, North America | www.fluidigm.com |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | www.agilent.com |
| Pacific Biosciences of California Inc | View profile | 796 | 1305 O’Brien Drive, Menlo Park, CA, United States, 94025 | www.pacb.com |
| Oxford Nanopore Technologies PLC | View profile | 1,133 | Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, United Kingdom, OX4 4DQ | www.nanoporetech.com |
| BioLine Rx Ltd ADR | View profile | 79 | 2 HaMa’ayan Street, Modi’in, Israel, 7177871 | www.biolinerx.com |
Japan Single Molecule, Real-Time (SMRT) Sequencing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Single Molecule, Real-Time (SMRT) Sequencing Market Outlook will help companies and investors design strategic landscapes.
Sequencing was the largest segment with a revenue share of 54.4% in 2020.
Horizon Databook has segmented the Japan single molecule, real-time (smrt) sequencing market based on pre-sequencing, sequencing, data analysis covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing number of rare genetic diseases, moving the attention of Japanese scientists towards rare disease research and the rise in adoption of SMRT sequencing technology more rapidly.
According to surveys conducted by the Japan Agency for Medical Research and Development (AMED) have represented that there are over 37,000 undiagnosed diseases cases, demonstrating that diagnosing patients with such rare and undiagnosed disorders are a major concern for the country.
However, researchers at Yokohama city university and other institutes in Japan established SMRT sequencing to research the genetic mechanism causes for progressive myoclonic epilepsy.
- Japan Single Molecule, Real-Time (Smrt) Sequencing Market Workflow Outlook (Revenue, USD Million , 2018-2030)
- Pre-Sequencing
- Sequencing
- Data Analysis
- Japan Single Molecule, Real-Time (Smrt) Sequencing Market Application Outlook (Revenue, USD Million , 2018-2030)
- Genomics
- Transcriptomics
- Epigenetics
- Japan Single Molecule, Real-Time (Smrt) Sequencing Market End-use Outlook (Revenue, USD Million , 2018-2030)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other
Reasons to subscribe to Single Molecule, Real-Time (SMRT) Sequencing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Single Molecule, Real-Time (SMRT) Sequencing Market Outlook databook
- Our clientele includes a mix of Single Molecule, Real-Time (SMRT) Sequencing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Single Molecule, Real-Time (SMRT) Sequencing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Single Molecule, Real-Time (SMRT) Sequencing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Japan Single Molecule, Real-Time (Smrt) Sequencing Market, 2018-2030 (US$M)
Japan single molecule, real-time (smrt) sequencing market statistics, by workflow, 2018-2030 (US$M)
